4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.
about
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@en
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@nl
type
label
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@en
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@nl
prefLabel
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@en
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@nl
P2093
P2860
P50
P1433
P1476
4-year results from the RAPID- ...... pegol in psoriatic arthritis.
@en
P2093
Alice B Gottlieb
Anthony Turkiewicz
Atul Deodhar
Bengt Hoepken
Jürgen Wollenhaupt
Lars Bauer
Luke Peterson
Majed Khraishi
Oliver FitzGerald
Oscar Irvin-Sellers
P2860
P304
P356
10.1136/RMDOPEN-2017-000582
P577
2018-03-14T00:00:00Z